ToolGen Incorporated
Research ToolGen Incorporated (199800.KQ) on Bullrun: market cap KRW 291.70B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker199800.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryBiotechnology
- CurrencyKRW
- Market capKRW 291.70B
- Financial periodQ2 2026
- RevenueKRW 487.20M
- Net income-KRW 6.78B
- Free cash flow-KRW 6.15B
- Gross margin90.8%
Valuation Snapshot
latest market cap is KRW 291.70B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 291.70B | n/a | n/a | n/a |
Dividend history
About ToolGen Incorporated
ToolGen Incorporated, a biotechnology company, focuses on the development of genome editing technology in South Korea. The company develops clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 gene scissors for gene editing in eukaryotic cells. It is involved in patent monetization, treatment, and seed businesses. ToolGen Incorporated was founded in 1999 and is based in Seoul, South Korea.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is ToolGen Incorporated's market cap?
ToolGen Incorporated's market capitalization is KRW 291.70B.
What does ToolGen Incorporated do?
ToolGen Incorporated, a biotechnology company, focuses on the development of genome editing technology in South Korea. The company develops clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 gene scissors for gene editing in eukaryotic cells. It is involved in patent monetization, treatment, and seed businesses. ToolGen Incorporated was founded in 1999 and is based in Seoul, South Korea.